Pharmaceutical companies have long experience in measuring the impact of their business programs. The same should apply to their access-to-medicine efforts
Richard Laing, from the Boston University (BU) School of Public Health and former World Health Organization official, says that many efforts to expand access to medicines fail to gather sufficient evidence on how effective they are. His team at BU recently issued a study highlighting these gaps, and emphasizing the need for companies to better document the impact of their programs.
Making our cities into places of wellbeing, exciting growth and opportunity will require every sector to join forces on urban health, says Dr. Ann Aerts, Head of the Novartis Foundation.
By Dr. Ann Aerts, Head of the Novartis Foundation
Walking through the wealthier streets of cities like Geneva, London or New York, it seems that health and fitness is an international obsession. National food chains boast of fresh ingredients, light options, and low-fat meals. Shelves are stacked with the trendiest superfoods – quinoa, chia seeds, kale and avocado.
Better Hearts Better Cities is an initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension
Better Hearts Better Cities is a Novartis Foundation initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension.
Non-communicable diseases (NCDs), including cardiovascular disease, are a growing health crisis with 75% of NCD deaths occurring in low- and middle-income countries; this is compounded by rapid urbanization.
The innovative approach is being tested on three continents: in Mongolia, Senegal, and Brazil.
More than half the ASEAN region’s 630 million people are under age 30. Harald Nusser, Head of Novartis Social Business, says that to fight the rise of chronic disease in South East Asia we need to inform its youth on the importance of healthy lifestyles.
The Three Non-Communicable Diseases Collaboration Can Solve
The start of a new year often conjures up hopes of a new you – losing extra pounds, stopping that unhealthy habit, or making changes to enrich life overall. In fact, many of us are already trying to prevent bad health and create solutions for the solvable in ourselves.
Today's guest blog comes from Lilly's Vice President of Global Health Programs and Access, Dr. Evan Lee.
The UN is holding its second-ever standalone meeting on non-communicable diseases (NCDs) this week in New York City, where world’s political leaders and ministers of health will assess progress against the UN’s landmark 2011 Political Declaration on NCDs.
Today’s guest post comes from Craig Waugh, advisor for Lilly’s global health programs.
I have just returned from the second annual national NCD Summit in New Delhi with renewed energy from our day with leaders from across India, who are in search of answers to the increasing challenge of non-communicable diseases (NCDs) in their country. The summit focused on NCDs in general and diabetes specifically, which is a growing problem in India.